No buy transactions available for this period
No sell transactions available for this period
Nextbio Capital Management Lp filed its 13F report for Q4 2025 on February 13, 2026. The portfolio totaled 170.49 M reflecting a -100.00% change from the prior quarter, spanning 0 assets. The top 10 holdings comprised 70.0% of the portfolio, with Financials as the largest sector allocation. No significant position changes were reported during the quarter.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Nextbio Capital Management submitted their Form 13F-HR for the Q4 2025 period on 02/13/2026. This was the only submission for the quarter.
In the Q4 2025 filing, Nextbio Capital Management reported a managed portfolio value of 170.49 M, consisting of 23 individual positions.
This page displays the raw filing documents. To see which stocks Nextbio Capital Management bought or sold during Q4 2025, please visit Nextbio Capital Management's Portfolio Analysis page.